Venous Access Devices Market Share

North American Market Forecasts

North America industry is likely to account for largest revenue share of 35% by 2037. The USA and Canada are projected to have the largest shares, thus dominating the market. This can be accounted on the back of growing cases of chronic diseases including health concerns such as diabetes, kidney failure, and multiple sclerosis owing to this the regional market is anticipated to register substantial growth. In particular, the Abre vein self-expanding device was innovated and authorized by the Food and Drug Administration in 2020 in the United States

European Market Statistics

The market in the Europe region is set to grow notably by the end of the forecast period. A major increase in the production of generic drugs by various drug companies is expected to meet the need for delivery technology. This has resulted in a large product pipeline and higher returns for existing products, which is an important factor behind the sector's growth. According to press reports, catheters are soft tubes inserted into the largest vein near the heart of the patient.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of venous access devices is assessed at USD 8.89 billion.

The venous access devices market size was valued at USD 8.58 billion in 2024 and is expected to reach USD 15.21 billion by 2037, expanding at around 4.5% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of chronic disease and growing technological advancement will drive the market growth.

North America industry is likely to account for largest revenue share of 35% by 2037, due to rising substantial incidence of chronic diseases in the region.

The major players in the market are of Baxter International, C R Bard, Reinventing Venous Access, Becton Dickinson and Company, Boston Scientific Corporation, Teleflex Incorporated., and others.

Venous Access Devices Market Share